Skip to content

Effect of Rosemary (Rosmarinus officinalis) leaves powder in type 2 diabetes patients

Effect of Rosemary (Rosmarinus officinalis) leaves powder on glycemic indexes, lipid profile, total antioxidant capacity, SOD, GSH-Px and hs-CRP in patients with type 2 diabetes

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120415009472N23
Enrollment
90
Registered
2021-01-02
Start date
2021-04-21
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group (n=45): all patients receive relevant dietary recommendations and are asked not to change their diet and physical activity. Also, the participants of the interventio

Sponsors

Vice-chancellor for research Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 70 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study and signing of the consent form Diagnosis of type 2 diabetes (fasting blood sugar higher than or equal to 126mg / dl or two hours above 200mg / dl or random blood sugar above 200 with one of the symptoms of hyperglycemia or hyperlipidemia) At least one year of history of diabetes (diagnosis of diabetes based on a doctor's opinion) Serum triglyceride above 200 mg / dl. Age range 25 to 70 years old Their body mass index is 20-35 Do not take any antioxidant and dietary supplements during the last 2 months Not getting pregnant and breastfeeding Do not have other chronic and inflammatory diseases

Exclusion criteria

Exclusion criteria: Smoking and any Drugs Cardiovascular, renal or liver diseases Use any antioxidant and dietary supplement during the last two months Use of Insulin Alcohol consumption Any allergies (gastrointestinal or skin) to any antioxidant or multivitamin supplement

Design outcomes

Primary

MeasureTime frame
Fasting Blood Sugar (FBS). Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calorie meter method.;Fasting insulin. Timepoint: Before intervention and 12 week after intervention. Method of measurement: ELISA.;LDL-C. Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calorie meter method.;HDL-C. Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calorie meter method.;Total triglyceride. Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calorie meter method.;Total cholesterol. Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calorie meter method.;HOMA- Insulin resistance. Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calculation.;Quantitative insulin sensitivity check index (QUICKI). Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calculation.;High sensitivity C-reactive protein. Timepoint: Before intervention and 12 week after intervention. Method of measurement: Immunoturbidimetric method.;Total Antioxidant Capacity. Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calorie meter method.;Superoxide dismutase (SOD). Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calorie meter method.;Glutathione peroxidase (GSH-PX). Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calorie meter method.

Secondary

MeasureTime frame
Micronutrients and Macronutrients intake. Timepoint: Before intervention and 12 week after intervention. Method of measurement: 24 hour recall questionnaire.;Weight. Timepoint: Before intervention and 12 week after intervention. Method of measurement: scales.;Height. Timepoint: Before intervention and 12 week after intervention. Method of measurement: meter.;Waist. Timepoint: Before intervention and 12 week after intervention. Method of measurement: Meter.;Body Mass Index (BMI). Timepoint: Before intervention and 12 week after intervention. Method of measurement: Calculation.;Systolic blood pressure. Timepoint: Before intervention and 12 week after intervention. Method of measurement: Digital barometric.;Diastolic blood pressure. Timepoint: Before intervention and 12 week after intervention. Method of measurement: Digital barometric.;Physical activity. Timepoint: Before intervention and 12 week after intervention. Method of measurement: International Physical Activity Questionnaire (IPAQ).;Total energy intake. Timepoint: Before intervention and 12 week after intervention. Method of measurement: 24 hour recall questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Nahid Aryaeian

Iran University of Medical Sciences

n-aryaeian@sina.tums.ac.ir+98 21 8670 4750

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026